IT8167642A0 - Composizione oftalmica - Google Patents

Composizione oftalmica

Info

Publication number
IT8167642A0
IT8167642A0 IT8167642A IT6764281A IT8167642A0 IT 8167642 A0 IT8167642 A0 IT 8167642A0 IT 8167642 A IT8167642 A IT 8167642A IT 6764281 A IT6764281 A IT 6764281A IT 8167642 A0 IT8167642 A0 IT 8167642A0
Authority
IT
Italy
Prior art keywords
ophthalmic composition
ophthalmic
composition
Prior art date
Application number
IT8167642A
Other languages
English (en)
Other versions
IT1205366B (it
Inventor
Kaoru Yamamori Yoshihir Komuro
Yoshiya Mamahira
Takeshi Noguchi
Original Assignee
Sumitomo Chemical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP6355680A external-priority patent/JPS56158714A/ja
Priority claimed from JP6355580A external-priority patent/JPS56158713A/ja
Application filed by Sumitomo Chemical Co filed Critical Sumitomo Chemical Co
Publication of IT8167642A0 publication Critical patent/IT8167642A0/it
Application granted granted Critical
Publication of IT1205366B publication Critical patent/IT1205366B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IT67642/81A 1980-05-13 1981-05-12 Composizione oftalmica IT1205366B (it)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP6355680A JPS56158714A (en) 1980-05-13 1980-05-13 Eye drop for glaucoma
JP6355580A JPS56158713A (en) 1980-05-13 1980-05-13 Eye drop

Publications (2)

Publication Number Publication Date
IT8167642A0 true IT8167642A0 (it) 1981-05-12
IT1205366B IT1205366B (it) 1989-03-15

Family

ID=26404686

Family Applications (1)

Application Number Title Priority Date Filing Date
IT67642/81A IT1205366B (it) 1980-05-13 1981-05-12 Composizione oftalmica

Country Status (8)

Country Link
US (1) US4396625A (it)
AU (1) AU540885B2 (it)
CA (1) CA1158167A (it)
CH (1) CH645806A5 (it)
DE (1) DE3119051A1 (it)
FR (1) FR2484941B1 (it)
GB (1) GB2077588B (it)
IT (1) IT1205366B (it)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3508665A1 (de) * 1985-03-12 1986-09-18 Hoechst Ag, 6230 Frankfurt Heterocyclische sulfide und ihre anwendung als immunmodulatoren
IL80298A (en) * 1986-10-14 1993-01-31 Res & Dev Co Ltd Eye drops
US5500230A (en) * 1987-01-23 1996-03-19 The General Hospital Corporation Method for treatment of glaucoma with nitrogen containing guanylate cyclase activators
JP2522112Y2 (ja) * 1989-09-12 1997-01-08 本田技研工業株式会社 自動変速機を備えた車両用の内燃機関の制御装置
DE4229494A1 (de) * 1992-09-04 1994-03-10 Basotherm Gmbh Arzneimittel zur topischen Anwendung am Auge zur Behandlung des erhöhten intraokularen Drucks
US5922773A (en) * 1992-12-04 1999-07-13 The Children's Medical Center Corp. Glaucoma treatment
US6482854B1 (en) 1999-03-25 2002-11-19 Massachusetts Eye And Ear Infirmary Glaucoma treatment
US20070224278A1 (en) 2003-11-12 2007-09-27 Lyons Robert T Low immunogenicity corticosteroid compositions
US20050101582A1 (en) 2003-11-12 2005-05-12 Allergan, Inc. Compositions and methods for treating a posterior segment of an eye
JP2007518804A (ja) 2004-01-20 2007-07-12 アラーガン、インコーポレイテッド トリアムシノロンアセトニドおよびヒアルロン酸を好ましく含有する眼局所治療用組成物
US20050231688A1 (en) * 2004-04-01 2005-10-20 Jones Peter W J Retinal screening using a night vision device
US7799336B2 (en) * 2004-04-30 2010-09-21 Allergan, Inc. Hypotensive lipid-containing biodegradable intraocular implants and related methods
US8673341B2 (en) 2004-04-30 2014-03-18 Allergan, Inc. Intraocular pressure reduction with intracameral bimatoprost implants
WO2005110374A1 (en) * 2004-04-30 2005-11-24 Allergan, Inc. Intraocular drug delivery systems containing a therapeutic component, a cyclodextrin, and a polymeric component
US20050244478A1 (en) * 2004-04-30 2005-11-03 Allergan, Inc. Anti-excititoxic sustained release intraocular implants and related methods
US8147865B2 (en) 2004-04-30 2012-04-03 Allergan, Inc. Steroid-containing sustained release intraocular implants and related methods
US20070059336A1 (en) * 2004-04-30 2007-03-15 Allergan, Inc. Anti-angiogenic sustained release intraocular implants and related methods
US7771742B2 (en) 2004-04-30 2010-08-10 Allergan, Inc. Sustained release intraocular implants containing tyrosine kinase inhibitors and related methods
US8455656B2 (en) 2004-04-30 2013-06-04 Allergan, Inc. Kinase inhibitors
US20050244458A1 (en) * 2004-04-30 2005-11-03 Allergan, Inc. Sustained release intraocular implants and methods for treating ocular neuropathies
US20050244461A1 (en) * 2004-04-30 2005-11-03 Allergan, Inc. Controlled release drug delivery systems and methods for treatment of an eye
US8425929B2 (en) * 2004-04-30 2013-04-23 Allergan, Inc. Sustained release intraocular implants and methods for preventing retinal dysfunction
US8722097B2 (en) 2004-04-30 2014-05-13 Allergan, Inc. Oil-in-water method for making polymeric implants containing a hypotensive lipid
US20050244465A1 (en) * 2004-04-30 2005-11-03 Allergan, Inc. Drug delivery systems and methods for treatment of an eye
US7993634B2 (en) * 2004-04-30 2011-08-09 Allergan, Inc. Oil-in-oil emulsified polymeric implants containing a hypotensive lipid and related methods
US9498457B2 (en) 2004-04-30 2016-11-22 Allergan, Inc. Hypotensive prostamide-containing biodegradable intraocular implants and related implants
BRPI0510485A (pt) 2004-04-30 2007-11-13 Allergan Inc implantes inibidores de tirosina cinase intravìtreos biodegradáveis
US20050244466A1 (en) * 2004-04-30 2005-11-03 Allergan, Inc. Photodynamic therapy in conjunction with intraocular implants
US20050244463A1 (en) * 2004-04-30 2005-11-03 Allergan, Inc. Sustained release intraocular implants and methods for treating ocular vasculopathies
US20050244471A1 (en) * 2004-04-30 2005-11-03 Allergan, Inc. Estradiol derivative and estratopone containing sustained release intraocular implants and related methods
US8119154B2 (en) 2004-04-30 2012-02-21 Allergan, Inc. Sustained release intraocular implants and related methods
US20050244462A1 (en) * 2004-04-30 2005-11-03 Allergan, Inc. Devices and methods for treating a mammalian eye
US8969415B2 (en) 2006-12-01 2015-03-03 Allergan, Inc. Intraocular drug delivery systems
US7911053B2 (en) * 2007-04-19 2011-03-22 Marvell World Trade Ltd. Semiconductor packaging with internal wiring bus
MX2009011801A (es) * 2007-05-04 2009-11-13 Baush & Lomb Inc Composiciones para reducir, aminorar, tratar o evitar afeccion de ojo seco y metodos para elaboracion y uso de las mismas.
BR112012009841A2 (pt) * 2009-10-26 2016-11-29 Inotek Pharmaceuticals Corp formulação oftálmica e processo para a sua preparação
MX361709B (es) 2009-11-09 2018-12-07 Allergan Inc Composiciones y metodos para estimular el crecimiento del cabello.
WO2014127243A1 (en) 2013-02-15 2014-08-21 Allergan, Inc. Sustained drug delivery implant

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1435139A (en) * 1972-08-17 1976-05-12 Sumitomo Chemical Co Thiazole derivatives
JPS535670B2 (it) * 1973-07-04 1978-03-01

Also Published As

Publication number Publication date
FR2484941A1 (it) 1981-12-24
AU7005481A (en) 1981-11-19
CA1158167A (en) 1983-12-06
AU540885B2 (en) 1984-12-06
GB2077588A (en) 1981-12-23
DE3119051A1 (de) 1982-03-11
FR2484941B1 (it) 1983-12-23
US4396625A (en) 1983-08-02
CH645806A5 (de) 1984-10-31
IT1205366B (it) 1989-03-15
GB2077588B (en) 1983-11-09

Similar Documents

Publication Publication Date Title
IT1205366B (it) Composizione oftalmica
FI814064L (fi) Komposition innehaollande en foto-aktivator foer foerbaettrad blekning
FI812475L (fi) Heterocykliska kompositioner
BR8108493A (pt) Composicao de organopolissiloxano
LU90000I2 (fr) Omic
RO86318A (ro) Compozitii fungicide-erbicide
BE887534A (fr) Sandwichpaneelelement
BE889577A (nl) Golfvormsynthese
FI812257L (fi) Kompositioner innehaollande heterocykliska foereningar
RO82549A (ro) Compozitie erbicida
IT1136927B (it) Composizione anti-molluschi
FI811690L (fi) Cylinderlaos
BE889192A (fr) Recolteuse-hacheuse
BE889004A (nl) Grijper
BE889708A (fr) Sous-soleuse
IT1194818B (it) Composizione fotocromatica
RO81803A (ro) Compozitie erbicida
RO85532A (ro) Compozitie erbicida
RO81509A (ro) Compozitie erbicida sinergetica
DE3165798D1 (de) Compositions comprising e-prostaglandins
BE890439A (fr) Afdekbaanrol
RO82396A (ro) Compozitie erbicida
RO82132A (ro) Compozitie erbicida sinergetica
BE890703A (fr) Robinet-vanne
BE887835A (fr) Fluidumsysteem